Literature DB >> 32912740

The safety of orthokeratology in myopic children and analysis of related factors.

Peike Hu1, Yingying Zhao1, Duya Chen1, Hailong Ni2.   

Abstract

OBJECTIVE: To evaluate the safety of overnight orthokeratology (OK) wear and explore whether factors such as age, refraction and allergic conjunctivitis (AC) history were associated with corneal adverse events (AEs) incidence.
METHODS: Medical records of consecutive patients who started OK for myopia correction and continued for more than one year were retrospectively reviewed. Clinical data including sex, baseline age, spherical equivalent refraction (SER), and related medical histories were retrieved. A total of 489 eyes from 260 patients (age: 8-15 years; SER: -1.00 to -6.00 D) were included. Corneal adverse events were the primary outcome. The generalized estimating equations model was used to evaluate the effects of sex, age, SER, and allergic conjunctivitis history on corneal AE incidence over the one-year period.
RESULTS: A total of 111 eyes (22.7%) had corneal AE during the one-year follow-up (corneal staining [n = 106], corneal infiltration [n = 5]) and the incidence of significant AE was 6.9%. The corneal AE incidence was associated with age (OR = 0.874, 95%CI = 0.781-0.978, p = 0.019); SER (OR=0.632, 95%CI=0.531-0.754, p < 0.001); and AC (OR=1.706, 95%CI=1.017-2.860, p = 0.043). High refraction was the key risk factor for significant AE (OR=0.542, 95%CI=0.401-0.732, p < 0.001).
CONCLUSIONS: Orthokeratology is a safe option for children with myopia. Younger age, higher myopia, and AC were risk factors for corneal AE in OK wearers. Whereas, only higher myopia was a risk factor for significant AE.
Copyright © 2020 British Contact Lens Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  adverse event; allergic conjunctivitis; myopia; orthokeratology

Year:  2020        PMID: 32912740     DOI: 10.1016/j.clae.2020.08.011

Source DB:  PubMed          Journal:  Cont Lens Anterior Eye        ISSN: 1367-0484            Impact factor:   3.077


  2 in total

1.  Comparison of Two Main Orthokeratology Lens Designs in Efficacy and Safety for Myopia Control.

Authors:  Weiwei Lu; Rui Ning; Kai Diao; Yang Ding; Ruru Chen; Lei Zhou; Yan Lian; Colm McAlinden; Francis W B Sanders; Fangfang Xia; Jinhai Huang; Wanqing Jin
Journal:  Front Med (Lausanne)       Date:  2022-04-01

2.  One-year results of the Variation of Orthokeratology Lens Treatment Zone (VOLTZ) Study: a prospective randomised clinical trial.

Authors:  Biyue Guo; Sin Wan Cheung; Randy Kojima; Pauline Cho
Journal:  Ophthalmic Physiol Opt       Date:  2021-05-15       Impact factor: 3.117

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.